Skip to main content
Clinical Trials/TCTR20240804002
TCTR20240804002
Recruiting
Phase 3

Hemodynamic impacts of non-invasive ventilation modalities on very-preterm infants, a pilot study

Routine To Research(R2R), Siriraj0 sites30 target enrollmentAugust 4, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Routine To Research(R2R), Siriraj
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2024
End Date
March 14, 2026
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Routine To Research(R2R), Siriraj

Eligibility Criteria

Inclusion Criteria

  • 1\. Newborn infant with gestational age less than 32 weeks or body weight less than 1500 grams
  • 2\. Age between 72 hours and 14 days
  • 3\. Requiring nasal CPAP
  • 4\. Clinical stable

Exclusion Criteria

  • 1\. Life\-threatening anomalies such as Trisomy 13, Trisomy 18, Trisomy 21
  • 2\. Severe congenital neurological abnormality
  • 3\. Critical congenital heart disease except patent ductus arterioles, atrial septal defect

Outcomes

Primary Outcomes

Not specified

Similar Trials